Laboratorios Poen

Ownership

Private

Therapeutic Areas

Ophthalmology

Stage

Commercial

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Modalities

Small molecule (most ophthalmic drugs are small molecules)Nanoemulsion (for certain formulations)Gel-based drug delivery therapyOintment-based drug delivery therapyNutritional supplement (capsules)

Laboratorios Poen General Information

Laboratorios Poen has a broad commercial portfolio of prescription and over-the-counter ophthalmic products, including innovative preservative-free glaucoma treatments and lubricating eye drops. The company also offers nutritional supplements for ocular health. No clinical trial data or investigational pipeline was identified in public sources. Recent expansion includes acquisition of Dromex Biotech’s plant to increase manufacturing capacity. Products such as XEGREX LC® for glaucoma and GOTA-PC® for dry eyes are available commercially. No published clinical results were found.

Contact Information

Website

https://www.poen.com.ar/

Primary Industry

Biotech

Corporate Office

Buenos Aires, Buenos Aires
Argentina

Drug Pipeline

No pipeline data available

For full access to Laboratorios Poen's pipeline data

Book a demo

Key Partnerships

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Laboratorios Poen Funding

No funding data available

Early Stage VC (Series A)	04-Jun-2020	$38M	Completed	Phase 1
Seed Round	12-Feb-2019	$8.5M	Completed	Startup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more

To view Laboratorios Poen's complete valuation and funding history, request access »